Xichen Lin - Feb 2, 2023 Form 3 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Chief Scientific Officer
Signature
Jun Yoon, Attorney-in-Fact
Stock symbol
GPCR
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
3
Date filed
2/2/2023, 05:12 PM
Next filing
Mar 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GPCR Stock option (right to buy) Feb 2, 2023 Ordinary Shares 320K $0.34 Direct F1
holding GPCR Stock option (right to buy) Feb 2, 2023 Ordinary Shares 148K $0.48 Direct F2
holding GPCR Stock option (right to buy) Feb 2, 2023 Ordinary Shares 100K $1.21 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
F2 The shares shall vest in a series of 48 successive equal monthly installments beginning one month after July 22, 2020.
F3 The shares shall vest in a series of 48 successive equal monthly installments beginning one month after September 16, 2021.